D-1293-2022 Class II Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

Recall Details

Product Type
Drugs
Report Date
August 3, 2022
Initiation Date
July 18, 2022
Termination Date
November 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,600 bottles

Product Description

Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90

Reason for Recall

Failed dissolution specifications.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: IB220023A, exp. date 08/2022